Quagen Promethazine with Codeine Oral Solution

Managing persistent coughing requires dependable clinical solutions. Quagen promethazine codeine oral solution provides targeted relief for adults experiencing severe cough and upper respiratory discomfort caused by allergies or common colds. Manufactured by Quagen Pharmaceuticals LLC, this prescription medication combines dual active agents to reduce reflex coughing and ease nasal congestion. Patients seeking high quality options through our online Shop find trusted treatments tailored to their recovery needs.

Effective Respiratory Relief with Quagen Promethazine

The formulation targets stubborn cough symptoms while calming allergic responses. Each dose works systematically to restore breathing comfort during acute respiratory illnesses. Adults needing structured symptom care rely on Codeine combinations to manage daily routines without continuous interruption from harsh coughing spells.

Active Ingredients and Mechanism of Action

This oral solution contains two primary active ingredients formulated in exact proportions. Codeine phosphate acts directly upon the medullary cough center to quiet involuntary urge signals. Simultaneously, promethazine hydrochloride supplies antihistaminic action, reducing mucosal swelling, sneezing, and runny nose.

Product Specifications and Dosage Information

Proper administration ensures maximum therapeutic benefit while keeping patient safety paramount. Adults eighteen years and older take five milliliters every four to six hours as directed by a physician. Total daily intake must never exceed thirty milliliters in twenty-four hours.

Key Dosage Guidelines:

• Use an accurate milliliter measuring device for every dose
• Do not increase dosing frequency or volume without medical consultation
• Limit treatment duration to the shortest effective period
• Reevaluate symptoms if cough persists beyond five days

Proper Usage and Safety Guidelines

Safety remains essential when administering prescription medications. Official regulatory records in the FDA Drug Database document approval under ANDA 214238 granted on October 8, 2020. Patients must avoid combining this oral solution with alcohol, benzodiazepines, or central nervous system depressants due to serious sedation risks. Review detailed guidance on MedlinePlus Health Information regarding opioid safety and drug interaction protocols. For patients transitioning off medication, gradual dose tapering prevents withdrawal symptoms.

Why Choose Quagen Pharma Products

Quagen Pharma maintains rigorous standards across manufacturing facilities located in West Caldwell, New Jersey. Led by experienced leadership, the company strictly follows current Good Manufacturing Practices to guarantee consistent product purity, potency, and safety. Learn more about our commitment to quality healthcare distribution on our About Us page.

Storage and Prescription Handling

Store the sixteen fluid ounce bottle at controlled room temperature between 15°C and 30°C (59°F to 86°F). Pharmacists supply this Schedule V controlled substance in tight, light-resistant containers equipped with child-resistant closures. Keep bottles safely secured to prevent unauthorized access or accidental ingestion. Customers looking for reliable therapeutic formulations explore our comprehensive selection of Painkillers to support complete personal health management.